NCT04693377
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +66 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Castration-Resistant Prostate Carcinoma
Explore clinical trials studying Castration-Resistant Prostate Carcinoma. Study availability and eligibility vary by location and protocol.
55 public trials
13 recruiting studies
Castration-Resistant Prostate Carcinoma trial results
NCT06288113
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +9 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +9 more
- Locations
-
- Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
- Highlands Oncology Group - Rogers Rogers, Arkansas, United States
- Highlands Oncology Group Springdale, Arkansas, United States
- Tibor Rubin VA Medical Center Long Beach, California, United States
Active, not recruiting
Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer
NCT02522715
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +11 more
- Locations
-
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Portland VA Medical Center Portland, Oregon, United States
- Seattle Cancer Care Alliance Seattle, Washington, United States
Active, not recruiting
Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
NCT02703623
- Conditions
- Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Genital Diseases, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- MD Anderson in Katy Houston, Texas, United States
- MD Anderson in Sugar Land Sugar Land, Texas, United States
Active, not recruiting
Testing the Safety of Different Doses of Olaparib Given Radium-223 for Men With Advanced Prostate Cancer With Bone Metastasis
NCT03317392
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- UC San Diego Moores Cancer Center La Jolla, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Smilow Cancer Center/Yale-New Haven Hospital New Haven, Connecticut, United States
- Yale University New Haven, Connecticut, United States
Active, not recruiting
Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer
NCT04592237
- Conditions
- Aggressive Variant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma, Genital Diseases, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations
NCT04550494
- Conditions
- Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
- Locations
-
- UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
Active, not recruiting
Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate Cancer
NCT06305598
- Conditions
- Castration-Resistant Prostate Carcinoma, Genital Diseases, Genital Diseases, Male, +10 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, not recruiting
Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel
NCT03419234
- Conditions
- Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Genital Diseases, +12 more
- Locations
-
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Kingman Regional Medical Center Kingman, Arizona, United States
- Mercy Hospital Fort Smith Fort Smith, Arkansas, United States